Omnicell Inc
NASDAQ:OMCL

Watchlist Manager
Omnicell Inc Logo
Omnicell Inc
NASDAQ:OMCL
Watchlist
Price: 45.45 USD -1.11% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Omnicell Inc?
Write Note

Omnicell Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Omnicell Inc
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Omnicell Inc
NASDAQ:OMCL
Total Current Assets
$1B
CAGR 3-Years
4%
CAGR 5-Years
16%
CAGR 10-Years
14%
Veeva Systems Inc
NYSE:VEEV
Total Current Assets
$5.4B
CAGR 3-Years
27%
CAGR 5-Years
27%
CAGR 10-Years
29%
Teladoc Health Inc
NYSE:TDOC
Total Current Assets
$1.6B
CAGR 3-Years
12%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Inspire Medical Systems Inc
NYSE:INSP
Total Current Assets
$582.5m
CAGR 3-Years
32%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Total Current Assets
$912.9m
CAGR 3-Years
63%
CAGR 5-Years
61%
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Total Current Assets
$222.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Omnicell Inc
Glance View

Market Cap
2.1B USD
Industry
Health Care

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Mountain View, California and currently employs 3,800 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. The firm's point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The firm's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility's in-house information management systems. The firm's Central Pharmacy IV Compounding Service offers a range of service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.

OMCL Intrinsic Value
45.57 USD
Fairly Valued
Intrinsic Value
Price

See Also

What is Omnicell Inc's Total Current Assets?
Total Current Assets
1B USD

Based on the financial report for Sep 30, 2024, Omnicell Inc's Total Current Assets amounts to 1B USD.

What is Omnicell Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
14%

Over the last year, the Total Current Assets growth was 11%. The average annual Total Current Assets growth rates for Omnicell Inc have been 4% over the past three years , 16% over the past five years , and 14% over the past ten years .

Back to Top